Cetero Research

 

Today's Research for Tomorrow's Healthcare

 
 
+
+
+
+
+
 
   
     
 
Complete Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  




  Compound Matrix Sensitivity Methodology
Mebendazole Plasma 1.00 ng/mL HPLC
Mefloquine Plasma 10.0 ng/mL HPLC
Megestrol Acetate Plasma 250 pg/mL LC/MS/MS
Meloxicam Plasma 10.0 ng/mL LC/MS/MS
Memantine Plasma 0.100 ng/mL LC/MS/MS
Mesalamine Plasma 2.00 – 1375 ng/mL LC/MS/MS
Mesalamine (Low Range) Plasma 2.00 ng/mL LC/MS/MS
Mesalamine / N-Acetylmesalamine Plasma 5.00 / 5.00 ng/mL LC/MS/MS
Metaxalone Dog Plasma 10.0 ng/mL LC/MS/MS
Metaxalone Plasma 10.0 ng/mL LC/MS/MS
Metformin Plasma 10.0 ng/mL LC/MS/MS
Methazolamide Whole Blood 0.200 µg/mL LC/MS/MS
Methazolamide Plasma 0.05-20 µg/mL LC/MS/MS
Methimazole Plasma 5.0 – 500.0 ng/mL LC/MS/MS
Methoxsalen Plasma 0.250 ng/mL LC/MS/MS
Methylergonovine Plasma 0.05000-6.000 ng/mL LC/MS/MS
Methylphenidate Plasma 0.100 ng/mL LC/MS/MS
Methylprednisolone Plasma 2.00 ng/mL LC/MS/MS
Metoclopramide (Low Range) Plasma 0.100 ng/mL LC/MS/MS
Metolazone Plasma 0.400 ng/mL LC/MS/MS
Metoprolol Plasma 0.0935 ng/mL LC/MS/MS
Metronidazole Plasma 0.500 ng/mL LC/MS/MS
Mexiletine Plasma 10.0 ng/mL HPLC
Midazolam and 1-Hydroxymidazolam Plasma 0.100/ 0.100 ng/mL LC/MS/MS
Midodrine / ST-1059 Plasma 0.500 / 0.500 ng/mL LC/MS/MS
Minocycline Plasma 20.0 ng/mL LC/MS/MS
Mirtazapine Plasma 0.250 ng/mL LC/MS/MS
Misoprostol Acid Plasma 5.00 pg/mL LC/MS/MS
Mitoxantrone Plasma 0.100-100 ng/mL LC/MS/MS
Modafinil Plasma 20.0 ng/mL LC/MS/MS
Moexipril / Moexiprilat Plasma 0.200 / 0.200 ng/mL LC/MS/MS
Montelukast Plasma 2.00 ng/mL LC/MS/MS
Morphine Plasma 0.500 ng/mL LC/MS/MS
Morphine / Morphine 6-Glucuronide (Low Range) Plasma 0.050/0.300 to 10.0/60.0 ng/mL LC/MS/MS
Moxifloxacin Plasma 40.0 ng/mL LC/MS/MS
Mycophenolate mofetil Plasma 20.0 pg/mL LC/MS/MS
Mycophenolic Acid Plasma 20.0 ng/mL LC/MS/MS


 

 
 
|
|
|
|
|
|
 
 
Developed by Web Interactive Technologies Baltimore Web Design